Chi Meng Fong
Stock Analyst at Bank of America Securities
(2.44)
# 3,102
Out of 4,685 analysts
42
Total ratings
50%
Success rate
7.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chi Meng Fong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Reiterated: Buy | $21 → $25 | $19.46 | +28.47% | 5 | Aug 7, 2026 | |
| ROIV Roivant Sciences | Reiterated: Hold | $35 → $37 | $36.75 | +0.68% | 26 | Aug 7, 2026 | |
| SUPN Supernus Pharmaceuticals | Maintained: Buy | $63 | $44.88 | +40.37% | 1 | Jul 13, 2026 | |
| CCCC C4 Therapeutics | Rated: Hold | n/a | $4.24 | n/a | 5 | Oct 31, 2023 | |
| FHTX Foghorn Therapeutics | Rated: Hold | n/a | $6.69 | n/a | 5 | Oct 6, 2023 |
Relay Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $21 → $25
Current: $19.46
Upside: +28.47%
Roivant Sciences
Aug 7, 2026
Reiterated: Hold
Price Target: $35 → $37
Current: $36.75
Upside: +0.68%
Supernus Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $63
Current: $44.88
Upside: +40.37%
C4 Therapeutics
Oct 31, 2023
Rated: Hold
Price Target: n/a
Current: $4.24
Upside: n/a
Foghorn Therapeutics
Oct 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.69
Upside: n/a